Scancell (LON:SCLP) Stock Price Passes Below 200-Day Moving Average – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 11.90 ($0.15) and traded as low as GBX 8.25 ($0.11). Scancell shares last traded at GBX 8.25 ($0.11), with a volume of 440,305 shares changing hands.

Scancell Trading Down 2.9 %

The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock’s fifty day moving average is GBX 8.98 and its 200 day moving average is GBX 11.90. The stock has a market cap of £85.45 million, a P/E ratio of -12.65 and a beta of 0.35.

Scancell (LON:SCLP) last announced its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. As a group, equities research analysts predict that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.